Current status of influenza: What do we know so far?
DOI:
https://doi.org/10.33448/rsd-v11i13.35808Keywords:
Viral Diseases; Severe Acute Respiratory Syndrome; Human flu; Pandemics.Abstract
Over the last years much research has been carried out, especially after the influenza pandemic in 2009. It is known that many strains of influenza virus are widely spread in the global population causing seasonal outbreaks every year. Influenza leads to flu-like symptoms, which present favorable prognosis, since most patients completely recover from it within two to five days. Many new antiviral drugs have been developed in the last few years, but since the infection generally presents a mild course, symptom-based care is often enough. Influenza virus can undergo mutations through some mechanisms, like antigenic drift and antigenic shift. Alongside with its high infectivity such mechanisms probably have worked together to keep influenza infection viable through the years, despite all new drugs and preventive measures. This review aimed to bring the most relevant data about influenza obtained in the past years, including some historical aspects, pathophysiology, clinical findings, and diagnostic and therapeutic approach.
References
Amarelle, L., Lecuona, E., & Sznajder, J. I. (2017). Tratamiento antigripal: fármacos actualmente utilizados y nuevos agentes en desarrollo. Arch Bronconeumol. 53(1): 19–26.
Amorim, C. de S. V., Pinheiro, I. F., Vieira, V. G. S., Guimarães, R. A., Nunes, P. S., & Marinho, T. A. (2018). Higiene das mãos e prevenção da influenza: conhecimento de discentes da área da saúde. Texto Contexto Enferm. 27(4), e4570017.
Bautista, E., Chotpitayasunondh, T., Gao, Z., Harper, S. A., Shaw, M., Uyeki T. M., Zaki, S. R., Hayden, F. G., Hui, D. S., Kettner, J. D., Kumar, A., Lim, M., Shindo, N., Penn, C., & Nicholson, K. G. (2010). Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 362(18), 1708-1719.
Bender, B. S., Croghan, T., Zhang, L., & Small, P. A. Jr. (1992). Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med. 175(4):1143-1145.
Bouvier, N. M., & Palese, P. (2008). The Biology of Influenza Viruses. Vaccine. 26(4), 49-53.
Brasil. (2019). Ministério da Saúde. Influenza: Monitoramento até a semana epidemiológica 30 de julho. https://portalarquivos2.saude.gov.br/images/pdf/2019/agosto/06/informe-influenza-30-27jul19.pdf
Bratincsák, A., El-Said, H. G., Bradley, J. S., Shayan, K., Gossfeld, P. D., & Cannavino, C. R. (2010). Fulminant Myocarditis Associated With Pandemic H1N1 Influenza A Virus. Revista J Am Coll Cardiol. 55(9): 928-929.
Carlson, A., Thung, S. F., & Norwitz, E. R. (2009). H1N1 Influenza in Pregnancy: What All Obstetric Care Providers Ought to Know. Rev Obstet Gynecol. 2(3), 139–145.
Casas-Aparicio, G. A., León-Rodríguez, I., Hernández-Zenteno, R. J., Castillejos-López, M., Barrera, C. A., Ormsby, C. E., & Reyes-Terán, G. (2018). Aggressive Fluid Accumulation Is Associated With Acute Kidney Injury and Mortality in a Cohort of Patients With Severe Pneumonia Caused by Influenza A H1N1 Virus. PLoS One. 13(2), e0192592.
Centers for Disease Control and Prevention, CDC. (2018). People at high risk for developing serious flu-related complications. https://www.cdc.gov/flu/highrisk/index.htm.
Centers for Disease Control and Prevention, CDC. (2019). Seasonal Influenza (Flu). https://www.cdc.gov/flu/index.htm
Centers for Disease Control and Prevention, CDC. (2020). Past Pandemics. https://www.cdc.gov/flu/pandemic-resources/basics/past-pandemics.html
Clements, D. A., Langdon, L., Bland, C., & Walter, E. (1995). Influenza A Vaccine Decreases the Incidence of Otitis Media in 6- To 30-month-old Children in Day Care. Arch Pediatr Adolesc Med. 149(10), 1113-1117.
Dharmapalan, D. (2020). Influenza. Indian J Pediatr. 87(10), 828-832.
Dobson, J., Whitley, R. J., Pocock, S., & Monto, A. S. (2015). Oseltamivir Treatment for Influenza in Adults: A Meta-Analysis of Randomised Controlled Trials. Lancet. 385(9979), 1729-1737.
Doherty, P. C., Topham, D. J., & Tripp, R. A. (1996). Establishment and Persistence of Virus-Specific CD4+ and CD8+ T Cell Memory. Immunol Rev. 150(1), 23-44.
Dovč, A., Premru, V., Pečavar, B., & Ponikvar, R. (2017). Acute Kidney Injury in Critically-Ill Adult Patients With Seasonal Influenza Infection. Clin Nephrol. 88(13): 18-21.
Forleo-Neto, E., Halker, E., Santos, V. J., Paiva, T. M., & Toniolo-Neto, J. (2003). Influenza. Rev Soc Bras Med Trop. 36(2), 267-274.
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa.
Fukao, K., Noshi, T., Yamamoto, A., Kitano, M., Ando, Y., & Noda, T. (2019). Combination Treatment With the Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil and a Neuraminidase Inhibitor in a Mouse Model of Influenza A Virus Infection. J Antimicrob Chemother. 74(3), 654-662.
Grant, E. J., Quiñones-Parra, S. M., Clemens, E. B., & Kedzierska, K. (2016). Human Influenza Viruses and CD8(+) T Cell Responses. Curr Opin Virol. 16(1), 132-142.
Harper, S. A., Fukuda, K., Uyeki, T. M., Cox, N. J., & Bridges, C. B. (2005). Prevention and Control of Influenza. MMWR. 54(8), 1-40.
Hart, A. M. (2019). Influenza: A Clinical Update Following a Century of Influenza Science. J Nurse Pract. 15(6), 429-433.
Hayden, F. G., Atmar, R. L., Schiling, M., Johnson, C., Poretz, D., & Paar, D. (1999). Use of the selective oral neuraminidase inhibitor oseltamivir for uncomplicated influenza in adults and adolescents. N Engl J Med. 341(18), 1336-1343.
Hayden, F. G., Sugaya, N., Hirotsu, N., Lee, N., De Jong, M. D., & Hurt, A. C. (2018). Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 379(10), 913–923.
Heikkinen, T., Ruuskanen, O., Waris, M., Ziegler, T., Arola, M., & Halonen, P. (1991). Influenza Vaccination in the Prevention of Acute Otitis Media in Children. Am J Dis Child. 145(4), 445-448.
Houser, K., & Subbarao, K. (2015). Influenza Vaccines: Challenges and Solutions. Cell Host Microbe. 17(3), 295-300.
Jameson, J. L., Fauci, A. S, Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. L. (2018). Principles of Internal Medicine. McGraw Hill.
Jędrzejek, M. J., & Mastalerz-Migas A. (2022). Seasonal influenza vaccination of healthcare workers: a narrative review. Int J Occup Med Environ Health. 35(2):127-139.
Jefferson, T., Jones, M., Doshi, P., Spencer, E. A., Onakpoya, I., & Heneghan, C. J. (2014). Oseltamivir for Influenza in Adults and Children: Systematic Review of Clinical Study Reports and Summary of Regulatory Comments. BMJ. 348(1):g2545.
Jia, L., Xie, J., Zhao, J., Cao, D., Liang, Y., Hou, X., Wang, L., & Li, Z. (2017). Mechanisms of Severe Mortality-Associated Bacterial Co-infections Following Influenza Virus Infection. Front Cell Infect Microbiol. 7(1), 338.
Kim, Y. H., Hong, K. J., Kim, H., & Nam, J. H. (2022). Influenza vaccines: Past, present, and future. Rev Med Virol, 32(1):e2243.
Kumar, V. (2016). Influenza in Children. Indian J Pediatr. 84(2): 139-143.
Labella, A. M., & Mersel, S. E. (2013). Influenza. Medical Clinics of North America. 97(1), 631-645.
Lee, J., Park, J. H., Jwa, H., & Kim, Y. H. (2017). Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis. Yonsei Med J. 58(4): 778-785.
Li, N., Parrish, M., Chan, T. K., Yin, L., Rai, P., Yoshiyuki, Y., Abolhassani, N., Tan, K. B., Kiraly, O., Chow, V. T. K., & Engelward, B. P. (2015). Influenza Infection Induces Host DNA Damage and Dynamic DNA Damage Responses During Tissue Regeneration. Cell Mol Life Sci. 72(15), 2973-2988.
Mameli, C., Cocchi, I., Fumagalli, M., & Zuccotti, G. (2019). Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population. Front Pediatr. 7, 317.
McMichael, A. J., Gotch, F. M., Nobre, G. R., & Beare, P. A. (1983). Cytotoxic T-cell Immunity to Influenza. N Engl J Med. 309(1):13-17.
Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (2015). Medical Microbiology. Elsevier.
Nakamura, K., Schwartz, B. S., Lindegårdh, N., Keh, C., & Guglielmo, B. J. (2010). Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis. 50(7), e47–49.
O’Hanlon, R., & Shaw, M. L. (2019). Baloxavir Marboxil: The New Influenza Drug on the Market. Curr Opin Virol. 35, 14-18.
Paules, C., & Subbarao, K. (2017). Influenza. Lancet. 390(10095), 697-708.
Peteranderl, C., Herold, S., & Schmoldt, C. (2016). Human Influenza Virus Infections. Semin Respir Crit Care Med. 37(4), 487-500.
Pittet, D. (2001). Compliance with hand disinfection and its impact on hospital-acquired infections. J Hosp Infect. 48(1), S40–S46.
Rewar, S., Mirdha, D., & Rewar, P. (2016). Treatment and Prevention of Pandemic H1N1 Influenza. Ann Glob Health. 81(5), 645–653.
Saunders-Hastings, P. R., & Krewski, D. (2016). Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission. Pathogens. 5(4), 66.
Sellers, S. A., Hagan, R. S., Hayden, F. G., & Fischer, W. A. (2017). The Hidden Burden of Influenza: A Review of the Extra-Pulmonary Complications of Influenza Infection. Influenza Other Respir Viruses. 11(5): 372-393.
Shim, J. M., Kim, J., Tenson, T., Min, J., & Kainov, D. E. (2017). Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis. Viruses. 9(8), 223.
Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013). Cellular Immune Correlates of Protection Against Symptomatic Pandemic Influenza. Nat Med. 19(10):1305-1312.
Taubenberger, J. K., & Morens, D. M. (2006). 1918 Influenza: the Mother of All Pandemics. Emerg Infect Dis. 12(1), 15-22.
Toovey, S., Prinssen, E. P., Rayner, C. R., Thakrar, B. T., Dutkowski, R., Koerner, A., Chu, T., Sirzen-Zelenskaya, A., Britschgi, M., Bansod, S., & Donner, B. (2012). Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review. Adv Ther. 29(10), 826–848.
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F., Harper, S. A., Hirshon, J. M., Ison, M. G., Johnston, B. L., Knight, S. L., McGeer, A., Riley, L. E., Wolfe, C. R., Alexander, P. E., & Pavia, A. T. (2019). Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis. 68(6): e1-e47.
Veronesi, R., & Focaccia, R. (2015). Tratado de Infectologia. Atheneu.
World Health Organization-WHO (2012). Weekly epidemiological record. https://www.who.int/wer/2012/wer8747.pdf?ua=1
Woźniak-Kosek, A., Kempińska-Mirosławska, B., & Hoser, G. (2014). Detection of the Influenza Virus Yesterday and Now. Acta Biochim Pol. 61(3), 465-470.
Yoshikura, H. (2014). Spanish Flu, Asian Flu, Hong Kong Flu, and Seasonal Influenza in Japan Under Social and Demographic Influence: Review and Analysis Using the Two-Population Model. Jpn J Infect Dis. 67(4), 245-257.
Zambon, M. C. (1999). Epidemiology and Pathogenesis of Influenza. J Antimicrob Chemother. 44(S1), 3-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Matheus Marques Martins Alexandre; Caio Manuel Caetano Adamian; Lucas de Menezes Galvão; Isadora Maria Praciano Lopes; Pedro Eduardo Andrade de Carvalho Gomes; Caroline Antunes de Almeida; Gdayllon Cavalcante Meneses ; Geraldo Bezerra da Silva Júnior; Roberto da Justa Pires Neto; Elizabeth de Francesco Daher
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
